Monday, 24 Feb 2020


Datesort descending Type Title Save
14 Jul 2016 Social in 428 SpA pts, BMI (obesity) has no effect on ASDAS. BMI weakly correlates w/ CRP, other PRO's.
18 Jul 2016 Social MTX in PsA yields min. Dz activity in <20%. MDA=5/7 SJC, PASI, entheses≤1, BSA≤3%, HAQ≤0.5, pt global≤20, Pt pain≤15
18 Jul 2016 Slide of the day Clinical Associations with Uveitis
18 Jul 2016 News SAPHO Syndrome Revisted
20 Jul 2016 Social Taurog & Colbert review #AS, ankylosing spondylitis & #SpA Spondyloarthritis in current NEJM.
22 Jul 2016 News FDA Panel Recommends Brodalumab Approval in Psoriasis
25 Jul 2016 News Novel Rise of Combined Dermatology-Rheumatology Clinics
04 Aug 2016 News RAPID3: An Effective Assessment Tool in Spondyloarthritis
05 Aug 2016 News Severe, Refractory Psoriasis in HIV-Positive Patients: Are TNF Inhibitors a Solution?
16 Aug 2016 News Fewer Psoriasis Patients Satisfied with Current Treatments
19 Aug 2016 Social Ankylosing spondylitis has 14% incr risk of cancer; GI tract (RR 1.20); M.myelomas (RR 1.92); lymphoma (RR 1.32)
23 Aug 2016 Social Confusing names: Spondylolysis, Spondylolisthesis, Spondylitis & Spondylosis explained.
23 Aug 2016 Social Structural progression is low (~5%) in early SpA; Sacroiliitis risk factors were B27, smoking & MRI SI inflammation
24 Aug 2016 News Adalimumab Controls Non-Infectious Uveitis in VISUAL II Study
27 Aug 2016 Social Ixekizumab (Taltz), IL-17 inhibitor, better than Placebo, but same as Humira @24wks in treating psoriatic arthritis
14 Sep 2016 News Adalimumab Lowers Risk of Uveitis Flares in Visual I Study
15 Sep 2016 Social RT @RonanTKavanagh: patients with psoriatic spondyloarthritis more steroid responsive than patients with Ank Spond (60% vs 20% at week 2. #…
19 Sep 2016 Social Why I Luv Rheum: Sitting next to me, 1 swollen PIP w/ onycholysis= I know its Psoriatic Arthritis I can help!! #RDAM
29 Sep 2016 Social Taiwan: HIV population higher risk for Sjögrens(SIR=1.64), psoriasis(2.05), SLE (2.59), AIHA (35.06), Uveitis (2.50)
03 Oct 2016 News Anti-IL-23 Guselkumab Beats Adalimumab in Severe Psoriasis